Dr. Robin Smith shares tip and insight with Investors Business Daily shares about increasing a company's value through M&A.
Dr. Robin Smith spoke with Drug Discovery News about NeoStem's new Targeted Immunotherapy Program and its expected launch of a Phase 3 trial for metastatic melanoma.
Dr. Robin Smith speaks on the powerful potential of cell-based therapies to change how we treat advanced cancer.
NeoStem Profile by BTV
Business Television (BTV) visited NeoStem to speak with Dr. Robin Smith, Chairman and CEO, and Dr. Douglas Losordo,Chief Medical Officer,